|
|
||||||||


* Friedrich Miescher Institute for Biomedical Research, Novartis Research Foundation, Basel, Switzerland;
Institute for Pathology, University of Basel, Basel, Switzerland; and
Cutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129.
Here we show that mice lacking the zinc finger transcription factor Aiolos develop the symptoms of human systemic lupus erythematosus (SLE), which is characterized by the production of anti-dsDNA Ab and immune complex-mediated glomerulonephritis. This finding indicates that normal Aiolos function is necessary to maintain immune homeostasis and suppress the development of systemic autoimmune disease and implicates Aiolos as a possible candidate gene for SLE. Interestingly, Aiolos-null mice can no longer mount autoimmune reactions and completely fail to develop SLE when they are deficient for the B cell-specific transcription coactivator OBF-1. The lack of OBF-1 reverses several Aiolos mutant mouse phenotypes, such as B cell hyperproliferation, high expression of activation marker on B cells, and spontaneous germinal center formation. Unexpectedly, B cell development at the immature B cell stage is severely impaired in the bone marrow of Aiolos/OBF-1 double-deficient mice, demonstrating the key role of these factors in the transition from pre-B to immature B cells. Our results indicate that B cells play a crucial role in the development of SLE in Aiolos mutant mice and might be useful for the strategy of SLE treatment.
This article has been cited by other articles:
![]() |
R. Caballero, F. Setien, L. Lopez-Serra, M. Boix-Chornet, M. F. Fraga, S. Ropero, D. Megias, M. Alaminos, E. M. Sanchez-Tapia, M. C. Montoya, et al. Combinatorial effects of splice variants modulate function of Aiolos J. Cell Sci., August 1, 2007; 120(15): 2619 - 2630. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Forster, S. Gallinat, J. Jablonska, S. Weiss, H.-P. Elsasser, and W. Lutz p300 Protein Acetyltransferase Activity Suppresses Systemic Lupus Erythematosus-Like Autoimmune Disease in Mice J. Immunol., June 1, 2007; 178(11): 6941 - 6948. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bandyopadhyay, M. Dure, M. Paroder, N. Soto-Nieves, I. Puga, and F. Macian Interleukin 2 gene transcription is regulated by Ikaros-induced changes in histone acetylation in anergic T cells Blood, April 1, 2007; 109(7): 2878 - 2886. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bartholdy, C. Du Roure, A. Bordon, D. Emslie, L. M. Corcoran, and P. Matthias The Ets factor Spi-B is a direct critical target of the coactivator OBF-1 PNAS, August 1, 2006; 103(31): 11665 - 11670. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wang, S. A. John, J. L. Clements, D. H. Percy, K. P. Barton, and L. A. Garrett-Sinha Ets-1 deficiency leads to altered B cell differentiation, hyperresponsiveness to TLR9 and autoimmune disease Int. Immunol., September 1, 2005; 17(9): 1179 - 1191. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Corcoran, J. Hasbold, W. Dietrich, E. Hawkins, A. Kallies, S. L. Nutt, D. M. Tarlinton, P. Matthias, and P. D. Hodgkin Differential requirement for OBF-1 during antibody-secreting cell differentiation J. Exp. Med., May 2, 2005; 201(9): 1385 - 1396. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cortes and K. Georgopoulos Aiolos Is Required for the Generation of High Affinity Bone Marrow Plasma Cells Responsible for Long-Term Immunity J. Exp. Med., January 20, 2004; 199(2): 209 - 219. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |